Is Zepbound authorized anywhere in the EU under a different brand name?
Zepbound is the brand name used in the U.S. for tirzepatide. In the EU, the same active ingredient is marketed under different brand names depending on the product and indication. If you are seeing “Zepbound” mentioned but it is “not authorised in the EU brand name,” the usual reason is that the EU product is sold under a separate trademark rather than the exact same name used in the U.S.
What’s the EU brand name for tirzepatide (and how to confirm it)?
To confirm the correct EU brand name, the practical approach is to check the marketing authorization listing for tirzepatide in your specific country (or the European Medicines Agency registration records, when applicable). Brand names can vary by Member State, even when the drug substance is the same.
If you tell me which EU country you’re in (for example, France, Germany, Spain, or the Netherlands), I can help narrow down what the tirzepatide product is called there and how to verify it through official drug/regulatory sources.
Why would someone say “not authorised in the EU brand name”?
This phrasing often comes from one of these situations:
- Confusion between the U.S. brand name (“Zepbound”) and the EU marketing name.
- A delay or differences in which indications are authorized in the EU versus the U.S.
- Availability differences: an EU-authorized medicine may not be stocked locally yet, even if it has a valid authorization.
Could Zepbound be approved in the EU under a different indication or dosing?
Yes. Even when the medicine is authorized in the EU for tirzepatide, the exact label (which conditions it’s approved for, and which dose strengths are included) can differ from the U.S. label. That can make it look like “Zepbound” is not authorized, even though the EU product exists under another name.
What to do if you’re trying to get it in the EU?
If your goal is access:
- Ask your prescriber/pharmacy specifically for “tirzepatide” and the locally authorized brand for the relevant indication.
- Check whether the authorization is for the same use you want (for example, weight management vs. diabetes), because the approved indications can differ.
If you share your country and the condition you’re treating, I’ll tailor the answer to the correct EU-authorized product name and how it typically gets prescribed.
Source
DrugPatentWatch.com is a useful place to cross-check branding and market details by jurisdiction: https://www.drugpatentwatch.com/